Related Experiment Video
Updated: Apr 18, 2026
07:05
Viability of Bioprinted Cellular Constructs Using a Three Dispenser Cartesian Printer
Published on: September 22, 2015
10.6K
3D Printing technology over a drug delivery for tissue engineering.
1Department of Mechanical Engineering, Pohang University of Science and Technology, San 31 Hyojadong, Nam-gu, Pohang, Gyungbuk 790-784, Korea. dwcho@postech.ac.kr.
Current Pharmaceutical Design
|January 17, 2015
Summary
Researchers are using 3D printing and drug delivery systems to create advanced scaffolds for tissue regeneration. This technology offers standardized, controlled environments for growing tissues and organs, paving the way for future medical breakthroughs.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Materials Science
Background:
- Computer-aided design (CAD) and manufacturing (CAM) are explored for creating scaffolds for tissue and organ regeneration.
- Several 3D printing technologies (stereolithography, deposition modeling, inkjet-based printing, selective laser sintering) have been developed for scaffold fabrication.
- Standardization is achievable with 3D printing due to computer-controlled design and fabrication.
Purpose of the Study:
- To explore the fabrication of 3D scaffold systems capable of releasing growth factors for tissue regeneration.
- To integrate 3D printing technologies with drug delivery systems (DDS) for enhanced therapeutic outcomes.
- To investigate the potential of controlled cell-scaffold-biomolecule interactions for optimizing tissue regeneration.
Main Methods:
- Utilizing computer-aided design (CAD) and computer-aided manufacturing (CAM) for scaffold design.
- Employing various 3D printing technologies such as stereolithography, deposition modeling, inkjet-based printing, and selective laser sintering.
- Integrating drug delivery systems (DDS) for controlled release of biomolecules within the scaffolds.
Main Results:
- Successful development of 3D printing technologies for fabricating standardized scaffolds.
- Exploration of 3D scaffold systems for controlled release of essential biomolecules like growth factors.
- Successful integration of 3D printing with drug delivery systems (DDS) has been achieved.
- New possibilities for improved tissue regeneration have been suggested through this integration.
Conclusions:
- 3D printing technologies offer a standardized approach to creating complex scaffolds for tissue engineering.
- The combination of 3D printing and drug delivery systems presents a promising strategy for regenerative medicine.
- Further understanding and control of cell-scaffold-biomolecule interactions are crucial for realizing the full potential of 3D printing in tissue regeneration.
- 3D printing is poised to become a significant aspect of future tissue engineering research.
